Skip to main content

Advertisement

Log in

Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Hyperandrogenism in women with polycystic ovary syndrome (PCOS) could increase muscle mass and thereby pelvic floor muscle (PFM) strength, reducing the risk of urinary incontinence (UI). The aim of the present study was to assess PFM strength and UI among hyperandrogenic women with PCOS and a control group for comparison.

Methods

This is an observational, cross-sectional, case–control study. Seventy-nine women, aged 18 to 40 years with a mean body mass index (BMI) of 23.4 kg/cm2 were recruited at the University Hospital: PCOS (n = 36) and control group for comparison (n = 43). All PCOS women had clinical and/or laboratory hyperandrogenism (> 80 ng/dL) and control women had regular menstrual cycles. PFM strength was assessed by vaginal manometry. The International Consultation on Incontinence Questionnaire of Urinary Incontinence Short Form (ICIQ-UI SF) was used to assess UI. Descriptive analysis, analysis of variance (ANOVA) and Fisher’s exact test were used for statistical analyses.

Results

There was no statistically significant difference in mean PFM strength between the PCOS and the control group: 2.7 cm H2O (95 % CI −6.2–11.6) p = 0.55. The prevalence of UI was 18.6 % in the control group compared with 0 % in the PCOS group p < 0.01.

Conclusions

Women with PCOS showed absence of UI, but PFM strength did not differ from the control group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749

    Article  PubMed  CAS  Google Scholar 

  2. Sinha-Hikim I, Roth SM, Lee MI, Bhasin S (2003) Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 285:197–205

    Google Scholar 

  3. Bhasin S, Calof OM, Storer TW, Lee ML, Mazer NA, Jasuja R, Montori VM, Gao W, Dalton JT (2006) Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2:146–159

    Article  PubMed  CAS  Google Scholar 

  4. Douchi T, Yamamoto S, Oki T, Maruta K, Kuwahata R, Nagata Y (1999) Serum androgen levels and muscle mass in women with polycystic ovary syndrome. Obstet Gynecol 94:337–340

    Article  PubMed  CAS  Google Scholar 

  5. Nnodim JO (1999) Quantitative study of the effects of denervation and castration on the levator ani muscle of the rat. Anat Rec 1:324–333

    Article  Google Scholar 

  6. Nnodim JO (2001) Testosterone mediates satellite cell activation in denervated rat levator ani muscle. Anat Rec 1:19–24

    Article  Google Scholar 

  7. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2003) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47

    Article  Google Scholar 

  8. Cunningham SK, Loughlin T, Culliton M, McKenna TJ (1985) The role of sex steroids and sex hormone binding globulin in hirsutism and/or oligomenorrhoea in obese and normal weight women. Ir Med J 78:208–212

    PubMed  CAS  Google Scholar 

  9. Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322–330

    Article  PubMed  Google Scholar 

  10. Tamanini JT, Dambros M, D’Ancona CA, Palma PC, Rodrigues Netto N Jr (2004) Validation of the “international consultation on incontinence questionnaire-Short form” (ICIQ-SF) for Portuguese. Rev Saude Publica 38:438–444

    Article  PubMed  Google Scholar 

  11. Klovning A, Avery K, Sandvik H, Hunskaar S (2009) Comparison of Two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn 28:411–415

    Article  PubMed  Google Scholar 

  12. Messelink B, Benson T, Berghmans B, Bø K, Corcos J, Fowler C, Laycock J, Lim PH, van Lunsen R, Nijeholt GL, Pemberton J, Wang A, Watier A, Van Kerrebroeck P (2005) Standardisation of terminology of pelvic floor muscle function and dysfunction: report from the pelvic floor clinical assessment group of the International Continence Society. Neurourol Urodyn 24:374–380

    Article  PubMed  Google Scholar 

  13. Laycock J (1994) Clinical evaluation of pelvic floor. In: Schussler B, Laycock J, Norton P, Stanton S (eds) Pelvic floor re-education. Springer, London, pp 42–48

    Google Scholar 

  14. Bo K, Sherburn M (2005) Evaluation of female pelvic-floor muscle function and strength. Phys Ther 85:269–282

    PubMed  Google Scholar 

  15. Hundley AF, Wu JM, Visco AG (2005) A comparison of perineometer to brink score for assessment of pelvic floor muscle strength. Am J Obstet Gynecol 192:1583–1591

    Article  PubMed  Google Scholar 

  16. Ferreira CH, Barbosa PB, de Oliveira SF, Antônio FI, Franco MM, Bø K (2011) Inter-rater reliability study of the modified Oxford grading scale and the Peritron manometer. Physiotherapy 97:132–138

    Article  PubMed  Google Scholar 

  17. Bo K, Kvarstein B, Hagen RR, Larsen S (1990) Pelvic floor muscle exercise for the treatment of female stress urinary-incontinence. II. Validity of vaginal pressure measurements of pelvic floor muscle strength and the necessity of supplementary methods for control of correct contraction. Neurourol Urodyn 9:479–487

    Article  Google Scholar 

  18. Montgomery DC (2000) Design and analysis of experiments, 5th edn. Wiley, New York

  19. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A (1995) Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269:E820–E826

    PubMed  CAS  Google Scholar 

  20. Brodsky IG, Balagopal P, Nair KS (1996) Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men—a clinical research center study. J Clin Endocrinol Metab 81:3469–3475

    Article  PubMed  CAS  Google Scholar 

  21. Douchi T, Yoshimitsu N, Nagata Y (2001) Relationships among serum testosterone levels, body fat and muscle mass distribution in women with polycystic ovary syndrome. Endocr J 48:685–689

    Article  PubMed  CAS  Google Scholar 

  22. DeLancey JO (1994) Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol 170:1713–1730

    PubMed  CAS  Google Scholar 

  23. DeLancey JO, Kearney R, Chou Q, Speights S, Binno S (2003) The appearance of levatorani muscle abnormalities in magnetic resonance images after vaginal delivery. Obstet Gynecol 101:46–53

    Article  PubMed  Google Scholar 

  24. Mammadov R, Simsir A, Tuglu I, Evren V, Gurer E, Özyurt C (2011) The effect of testosterone treatment on urodynamic findings and histopathomorphology of pelvic floor muscles in female rats with experimentally induced stress urinary incontinence. Int Urol Nephrol 43:1003–1008

    Article  PubMed  CAS  Google Scholar 

  25. Montezuma T, Antônio FI, Rosa e Silva AC, de Sá MF, Ferriani RA, Ferreira CH (2011) Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome. Clinics 66:1911–1915

    Article  PubMed  Google Scholar 

  26. Jung J, Ahn HK, Huh Y (2012) Clinical and functional anatomy of the urethral sphincter. Int Neurourol J 16:102–106

    Article  PubMed  Google Scholar 

  27. Bo K, Berghmans B, Morkved S, Van Kampen M (2007) Evidence-based physical therapy for the pelvic floor: bridging science and clinical practice, 1st edn. Elsevier, Philadelphia, pp 164–167

    Google Scholar 

  28. Thom D (1998) Variations in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 46:473–480

    PubMed  CAS  Google Scholar 

  29. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ (2008) Pelvic floor disorders network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300:1311–1316

    Article  PubMed  CAS  Google Scholar 

  30. Milsom I, Altman D, Lapitan MC, Nelson R, Sillén U, Thom D (2009) Epidemiology of urinary (UI) and faecal (FI) incontinence and pelvic organ prolapse (POP). ICS Publications, Bristol

    Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the financial support of the Foundation for the Support of Research of São Paulo State (FAPESP) and from the Foundation for the support of Teaching, Research and Service (FAEPA) of the Clinics Hospital of the Faculty of Medicine of Ribeirão Preto of the University of Sao Paulo.

Funding

Foundation for the Support of Research of São Paulo State (FAPESP) and from the Foundation for the support of Teaching, Research and Service (FAEPA) of the Clinics Hospital of the Faculty of Medicine of Ribeirão Preto of the University of Sao Paulo.

Financial disclaimer/Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristine Homsi Jorge Ferreira.

Additional information

Brief summary

Pelvic floor muscle strength did not differ between the groups, but women with polycystic ovary syndrome showed absence of urinary incontinence

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antônio, F.I., Bo, K., Ferriani, R.A. et al. Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome. Int Urogynecol J 24, 1709–1714 (2013). https://doi.org/10.1007/s00192-013-2095-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-013-2095-x

Keywords

Navigation